# A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

> **NCT07081932** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nerandomilast
- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT07081932
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-26
- **Primary completion:** 2025-09-27
- **Final completion:** 2025-10-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07081932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07081932, "A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07081932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*